Matthew Herper covers medical innovation — both its promise and its perils. Eli Lilly will pay up to $2.4 billion to acquire Orna Therapeutics, a biotechnology firm that is developing a technology to ...

Feb 9 (Reuters) – Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients’ own cells to generate therapies inside the body, without the ...

One of the world’s largest pharmaceutical companies, Eli Lilly, announced on Monday that it is acquiring the Watertown-based biotech Orna Therapeutics for $2.4 billion. Orna is developing a new ...

Eli Lilly (LLY) has agreed to acquire biotechnology company Orna Therapeutics for up to $2.4B in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain clinical ...

Eli Lilly and Co. on Monday announced it will pay up to $2.4 billion in cash to acquire Watertown, Massachusetts-based Orna Therapeutics, a biotech company that is developing a technology that helps a ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

Eli Lilly snaps up Watertown biotech in $2.4 billion deal Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers.